{
    "startDate": "2018-01-01",
    "endDate": "2018-06-30",
    "year": "2018",
    "quarter": "Q2",
    "symbol": "BHVN",
    "data": {
        "bs": [
            {
                "label": "Cash",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 217452000
            },
            {
                "label": "Prepaid Expense and Other Assets, Current [Abstract]",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 10150000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 227602000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3792000
            },
            {
                "label": "Equity Method Investments and Joint Ventures [Abstract]",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": 7853000
            },
            {
                "label": "Other",
                "concept": "OtherAssets",
                "unit": "usd",
                "value": 43000
            },
            {
                "label": "Financial assets at fair value",
                "concept": "Assets",
                "unit": "usd",
                "value": 239290000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 4027000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 8728000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 12755000
            },
            {
                "label": "Liability related to sale of future royalties, net",
                "concept": "bhvn:LiabilityForSaleOfFutureRoyaltiesCarryingAmountNet",
                "unit": "usd",
                "value": 106282000
            },
            {
                "label": "Measurement input for warrant liability",
                "concept": "WarrantsAndRightsOutstanding",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1423000
            },
            {
                "label": "Liabilities and Shareholders\u2019 Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 120460000
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock value",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 413225000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 32982000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -327377000
            },
            {
                "label": "Total shareholders\u2019 equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 118830000
            },
            {
                "label": "Liabilities and Shareholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 239290000
            }
        ],
        "cf": [
            {
                "label": "Net losses",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -124731000
            },
            {
                "label": "Share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 8696000
            },
            {
                "label": "Non-cash interest expense",
                "concept": "bhvn:NoncashInterestExpense",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Non-cash interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 501000
            },
            {
                "label": "Change in fair value of warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 1182000
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "bhvn:FairValueAdjustmentOfDerivativeLiability",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of contingent equity liability",
                "concept": "bhvn:FairValueAdjustmentOfContingentEquityLiability",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -1369000
            },
            {
                "label": "Other non-cash items",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -53000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 4953000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": 11000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -694000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 3643000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "IncreaseDecreaseInOtherNoncurrentLiabilities",
                "unit": "usd",
                "value": -44000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -114989000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 1501000
            },
            {
                "label": "Cash payment for purchase of equity method investment",
                "concept": "PaymentsToAcquireEquityMethodInvestments",
                "unit": "usd",
                "value": 1375000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -2876000
            },
            {
                "label": "Proceeds from sale of common stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 55000000
            },
            {
                "label": "Proceeds from sale of future royalties",
                "concept": "bhvn:ProceedsSaleOfFutureRoyaltiesNetOfIssuanceCosts",
                "unit": "usd",
                "value": 106047000
            },
            {
                "label": "Proceeds from issuance of common stock related to sale of future royalties",
                "concept": "bhvn:ProceedsFromIssuanceOfCommonStockRelatedToSaleOfFutureRoyaltiesNetOfIssuanceCosts",
                "unit": "usd",
                "value": 43953000
            },
            {
                "label": "Proceeds from issuance of Series A preferred shares",
                "concept": "ProceedsFromIssuanceOfConvertiblePreferredStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Payments of related party notes payable",
                "concept": "RepaymentsOfRelatedPartyDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other offering expenses",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 2987000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 1836000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 203849000
            },
            {
                "label": "Net increase in cash",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 85984000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cash paid for income taxes",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 23000
            },
            {
                "label": "Offering costs included in accounts payable and accrued expenses",
                "concept": "bhvn:DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses",
                "unit": "usd",
                "value": 377000
            },
            {
                "label": "Recognized fair value of BCF as a reduction to series A preferred shares and corresponding adjustment to additional paid in capital",
                "concept": "bhvn:BeneficialConversionFeatureValueConvertibleInstruments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accretion of beneficial conversion feature on Series A preferred shares",
                "concept": "bhvn:AccretionOfBeneficialConversionFeatureValueConvertibleInstruments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Issuance of Series A preferred shares as payment of offering costs",
                "concept": "bhvn:IssuanceOfSeriesPreferredStockAsPaymentOfOfferingCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Issuance of common shares as payment of equity investment",
                "concept": "bhvn:StockIssuedDuringPeriodValueEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            }
        ],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 104631000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 16921000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 121552000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -121552000
            },
            {
                "label": "Non-cash interest expense recognized, net of transaction cost amortization",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 21000
            },
            {
                "label": "Non-cash interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 501000
            },
            {
                "label": "Change in fair value of warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 1182000
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "bhvn:FairValueAdjustmentOfDerivativeLiability",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of contingent equity liability",
                "concept": "bhvn:FairValueAdjustmentOfContingentEquityLiabilityExcludingInitialCharge",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -1369000
            },
            {
                "label": "Other",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 6000
            },
            {
                "label": "Total other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -3067000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -124619000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 112000
            },
            {
                "label": "Net losses",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -124731000
            },
            {
                "label": "Accretion of beneficial conversion feature on Series A preferred shares",
                "concept": "bhvn:AccretionOfBeneficialConversionFeatureValueConvertibleInstruments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss attributable to common shareholders of Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -124731000
            },
            {
                "label": "Net loss per share attributable to common shareholders of Biohaven Pharmaceutical Holding Company Ltd.-basic and diluted (in dollars per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -3.29
            },
            {
                "label": "Weighted average common shares outstanding - basic and diluted (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 37873755
            }
        ]
    }
}